
### [MONDO:0016805](http://purl.obolibrary.org/obo/MONDO_0016805)
**Label:** isolated oxidative phosphorylation complex disorder

**Subclasses:** [MONDO:0014356](http://purl.obolibrary.org/obo/MONDO_0014356) (mitochondrial complex III deficiency nuclear type 7), [MONDO:0014471](http://purl.obolibrary.org/obo/MONDO_0014471) (isolated ATP synthase deficiency), [MONDO:0014064](http://purl.obolibrary.org/obo/MONDO_0014064) (mitochondrial complex III deficiency nuclear type 3), [MONDO:0014065](http://purl.obolibrary.org/obo/MONDO_0014065) (mitochondrial complex III deficiency nuclear type 4), [MONDO:0009640](http://purl.obolibrary.org/obo/MONDO_0009640) (mitochondrial complex i deficiency), [MONDO:0014066](http://purl.obolibrary.org/obo/MONDO_0014066) (mitochondrial complex III deficiency nuclear type 5), [MONDO:0009068](http://purl.obolibrary.org/obo/MONDO_0009068) (cytochrome-c oxidase deficiency disease), [MONDO:0014496](http://purl.obolibrary.org/obo/MONDO_0014496) (mitochondrial complex III deficiency nuclear type 9), [MONDO:0014364](http://purl.obolibrary.org/obo/MONDO_0014364) (mitochondrial complex III deficiency nuclear type 8), [MONDO:0009641](http://purl.obolibrary.org/obo/MONDO_0009641) (mitochondrial complex II deficiency), [MONDO:0014194](http://purl.obolibrary.org/obo/MONDO_0014194) (mitochondrial complex III deficiency nuclear type 6), [MONDO:0014063](http://purl.obolibrary.org/obo/MONDO_0014063) (mitochondrial complex III deficiency nuclear type 2), [MONDO:0014091](http://purl.obolibrary.org/obo/MONDO_0014091) (mitochondrial complex v (ATP synthase) deficiency nuclear type 4), [MONDO:0007415](http://purl.obolibrary.org/obo/MONDO_0007415) (mitochondrial complex III deficiency nuclear type 1), [MONDO:0011421](http://purl.obolibrary.org/obo/MONDO_0011421) (mitochondrial complex v (ATP synthase) deficiency, nuclear type 1), [MONDO:0015448](http://purl.obolibrary.org/obo/MONDO_0015448) (isolated CoQ-cytochrome c reductase deficiency), [MONDO:0016811](http://purl.obolibrary.org/obo/MONDO_0016811) (renal tubulopathy-encephalopathy-liver failure syndrome), [MONDO:0013547](http://purl.obolibrary.org/obo/MONDO_0013547) (mitochondrial complex v (ATP synthase) deficiency nuclear type 3), 

**Corr. equiv. classes:** [OMIM:220110](http://purl.obolibrary.org/obo/OMIM_220110), [Orphanet:2609](http://www.orpha.net/ORDO/Orphanet_2609), [OMIM:615160](http://purl.obolibrary.org/obo/OMIM_615160), [OMIM:616111](http://purl.obolibrary.org/obo/OMIM_616111), [OMIM:616045](http://purl.obolibrary.org/obo/OMIM_616045), [Orphanet:254902](http://www.orpha.net/ORDO/Orphanet_254902), [Orphanet:254913](http://www.orpha.net/ORDO/Orphanet_254913), [OMIM:614053](http://purl.obolibrary.org/obo/OMIM_614053), [OMIM:615158](http://purl.obolibrary.org/obo/OMIM_615158), [Orphanet:254905](http://www.orpha.net/ORDO/Orphanet_254905), [OMIM:615159](http://purl.obolibrary.org/obo/OMIM_615159), [OMIM:615453](http://purl.obolibrary.org/obo/OMIM_615453), [Orphanet:3208](http://www.orpha.net/ORDO/Orphanet_3208), [OMIM:615157](http://purl.obolibrary.org/obo/OMIM_615157), [OMIM:615228](http://purl.obolibrary.org/obo/OMIM_615228), [Orphanet:1460](http://www.orpha.net/ORDO/Orphanet_1460), [OMIM:604273](http://purl.obolibrary.org/obo/OMIM_604273), [OMIM:615838](http://purl.obolibrary.org/obo/OMIM_615838), [OMIM:615824](http://purl.obolibrary.org/obo/OMIM_615824), [OMIM:124000](http://purl.obolibrary.org/obo/OMIM_124000), [OMIM:252010](http://purl.obolibrary.org/obo/OMIM_252010), [OMIM:252011](http://purl.obolibrary.org/obo/OMIM_252011), 

**Class expressions from DL-Learner:**

- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 42.50%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001252](http://purl.obolibrary.org/obo/HP_0001252) (Muscular hypotonia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 42.50%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 41.73%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 40.74%
- Thing 40.73%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 40.73%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) 39.80%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 39.75%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 39.75%
- [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) 39.17%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 38.64%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 37.82%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0003128](http://purl.obolibrary.org/obo/HP_0003128) (Lactic acidosis) 36.57%
- [HP:0002151](http://purl.obolibrary.org/obo/HP_0002151) (Increased serum lactate) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 35.63%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 34.37%


